148 related articles for article (PubMed ID: 24817712)
1. A structural characterization of the isoniazid Mycobacterium tuberculosis drug target, Rv2971, in its unliganded form.
Shahine A; Prasetyoputri A; Rossjohn J; Beddoe T
Acta Crystallogr F Struct Biol Commun; 2014 May; 70(Pt 5):572-7. PubMed ID: 24817712
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure and comparative functional analyses of a Mycobacterium aldo-keto reductase.
Scoble J; McAlister AD; Fulton Z; Troy S; Byres E; Vivian JP; Brammananth R; Wilce MC; Le Nours J; Zaker-Tabrizi L; Coppel RL; Crellin PK; Rossjohn J; Beddoe T
J Mol Biol; 2010 Apr; 398(1):26-39. PubMed ID: 20188740
[TBL] [Abstract][Full Text] [Related]
3. Plant aldo-keto reductases (AKRs) as multi-tasking soldiers involved in diverse plant metabolic processes and stress defense: A structure-function update.
Sengupta D; Naik D; Reddy AR
J Plant Physiol; 2015 May; 179():40-55. PubMed ID: 25840343
[TBL] [Abstract][Full Text] [Related]
4. Study of mechanism of interaction of truncated isoniazid-nicotinamide adenine dinucleotide adduct against multiple enzymes of Mycobacterium tuberculosis by a computational approach.
Jena L; Deshmukh S; Waghmare P; Kumar S; Harinath BC
Int J Mycobacteriol; 2015 Dec; 4(4):276-83. PubMed ID: 26964808
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning, expression and catalytic activity of a human AKR7 member of the aldo-keto reductase superfamily: evidence that the major 2-carboxybenzaldehyde reductase from human liver is a homologue of rat aflatoxin B1-aldehyde reductase.
Ireland LS; Harrison DJ; Neal GE; Hayes JD
Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):21-34. PubMed ID: 9576847
[TBL] [Abstract][Full Text] [Related]
6. Novel Aldo-Keto Reductases for the Biocatalytic Conversion of 3-Hydroxybutanal to 1,3-Butanediol: Structural and Biochemical Studies.
Kim T; Flick R; Brunzelle J; Singer A; Evdokimova E; Brown G; Joo JC; Minasov GA; Anderson WF; Mahadevan R; Savchenko A; Yakunin AF
Appl Environ Microbiol; 2017 Apr; 83(7):. PubMed ID: 28130301
[TBL] [Abstract][Full Text] [Related]
7. The aldo-keto reductase (AKR) superfamily: an update.
Jez JM; Penning TM
Chem Biol Interact; 2001 Jan; 130-132(1-3):499-525. PubMed ID: 11306071
[TBL] [Abstract][Full Text] [Related]
8. Crystallographic analysis of a novel aldo-keto reductase from Thermotoga maritima in complex with NADP⁺.
Hou H; Li R; Wang X; Yuan Z; Liu X; Chen Z; Xu X
Acta Crystallogr F Struct Biol Commun; 2015 Jul; 71(Pt 7):847-55. PubMed ID: 26144229
[TBL] [Abstract][Full Text] [Related]
9. The xylose reductase (AKR2B5) structure: homology and divergence from other aldo-keto reductases and opportunities for protein engineering.
Wilson DK; Kavanagh KL; Klimacek M; Nidetzky B
Chem Biol Interact; 2003 Feb; 143-144():515-21. PubMed ID: 12604237
[TBL] [Abstract][Full Text] [Related]
10. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis.
Rozwarski DA; Grant GA; Barton DH; Jacobs WR; Sacchettini JC
Science; 1998 Jan; 279(5347):98-102. PubMed ID: 9417034
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium tuberculosis dihydrofolate reductase is a target for isoniazid.
Argyrou A; Vetting MW; Aladegbami B; Blanchard JS
Nat Struct Mol Biol; 2006 May; 13(5):408-13. PubMed ID: 16648861
[TBL] [Abstract][Full Text] [Related]
12. Identification and functional characterization of a novel aldo-keto reductase from Aloe vera.
Jangra A; Chaturvedi S; Sihag S; Sharma G; Tiwari S; Chhokar V
Planta; 2023 Oct; 258(6):107. PubMed ID: 37897513
[TBL] [Abstract][Full Text] [Related]
13. The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.
Barski OA; Tipparaju SM; Bhatnagar A
Drug Metab Rev; 2008; 40(4):553-624. PubMed ID: 18949601
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization of an aldo-keto reductase (AKR2E5) from the silkworm Bombyx mori.
Yamamoto K; Higashiura A; Suzuki M; Shiotsuki T; Sugahara R; Fujii T; Nakagawa A
Biochem Biophys Res Commun; 2016 May; 474(1):104-110. PubMed ID: 27103441
[TBL] [Abstract][Full Text] [Related]
15. The molecular basis of isoniazid resistance in Mycobacterium tuberculosis.
Heym B; Saint-Joanis B; Cole ST
Tuber Lung Dis; 1999; 79(4):267-71. PubMed ID: 10692996
[No Abstract] [Full Text] [Related]
16. Crystallographic studies on the binding of isonicotinyl-NAD adduct to wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.
Dias MV; Vasconcelos IB; Prado AM; Fadel V; Basso LA; de Azevedo WF; Santos DS
J Struct Biol; 2007 Sep; 159(3):369-80. PubMed ID: 17588773
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of isoniazid resistance in Mycobacterium tuberculosis: enzymatic characterization of enoyl reductase mutants identified in isoniazid-resistant clinical isolates.
Basso LA; Zheng R; Musser JM; Jacobs WR; Blanchard JS
J Infect Dis; 1998 Sep; 178(3):769-75. PubMed ID: 9728546
[TBL] [Abstract][Full Text] [Related]
18. AhpC, oxidative stress and drug resistance in Mycobacterium tuberculosis.
Sherman DR; Mdluli K; Hickey MJ; Barry CE; Stover CK
Biofactors; 1999; 10(2-3):211-7. PubMed ID: 10609885
[TBL] [Abstract][Full Text] [Related]
19. Synergistic Lethality of a Binary Inhibitor of Mycobacterium tuberculosis KasA.
Kumar P; Capodagli GC; Awasthi D; Shrestha R; Maharaja K; Sukheja P; Li SG; Inoyama D; Zimmerman M; Ho Liang HP; Sarathy J; Mina M; Rasic G; Russo R; Perryman AL; Richmann T; Gupta A; Singleton E; Verma S; Husain S; Soteropoulos P; Wang Z; Morris R; Porter G; Agnihotri G; Salgame P; Ekins S; Rhee KY; Connell N; Dartois V; Neiditch MB; Freundlich JS; Alland D
mBio; 2018 Dec; 9(6):. PubMed ID: 30563908
[TBL] [Abstract][Full Text] [Related]
20. Structure of porcine aldehyde reductase holoenzyme.
el-Kabbani O; Judge K; Ginell SL; Myles DA; DeLucas LJ; Flynn TG
Nat Struct Biol; 1995 Aug; 2(8):687-92. PubMed ID: 7552731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
